about
Clusterin silencing inhibits proliferation and reduces invasion in human laryngeal squamous carcinoma cellsOverexpression of miR -155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3.Value of open horizontal glottectomy in the treatment for T1b glottic cancer with anterior commissure involvement.MicroRNA-9 as a novel prognostic biomarker in human laryngeal squamous cell carcinoma.Relationship between CO2 laser-induced artifact and glottic cancer surgical margins at variable power doses.CXCR4 silencing inhibits invasion and migration of human laryngeal cancer Hep-2 cellsExpression of paxillin in laryngeal squamous cell carcinoma and its prognostic valueRehabilitation of dysphagia following head and neck cancerSignificance of Parafibromin Expression in Laryngeal Squamous Cell CarcinomasAssessment of the evolution of cancer treatment therapiesHead and neck cancer: an evolving treatment paradigm.New, Immunomodulatory, Oral Nutrition Formula for Use Prior to Surgery in Patients With Head and Neck Cancer: An Exploratory Study.Novel modification of voice prosthesis.Quality of life after total laryngectomy: functioning, psychological well-being and self-efficacy.Polydatin inhibits cell proliferation and induces apoptosis in laryngeal cancer and HeLa cells via suppression of the PDGF/AKT signaling pathway.[Imaging of the head and neck region].Association between XRCC3 Thr241Met polymorphism and laryngeal cancer susceptibility in Turkish population.C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance.
P2860
Q33593020-4650D15D-807D-46A0-BC15-6791349A9F71Q34598648-D91813C2-80F4-4DCD-AD7E-E48E05F3898CQ34789041-200070D7-D134-40C7-BEC8-06526B293607Q35017255-D3F1A6B0-2B1A-4792-9A06-97B37DA1486BQ35611012-A775EDAC-2FB1-466F-842A-59BE0C3E8CB1Q35918942-A9316BF7-0A89-4875-A105-46F5CCC17DF2Q36095220-66EA9E61-35B2-4246-9C04-9C46B3D3100EQ36994833-C119AB5A-2F8C-4D58-99BB-C3F003DE4858Q37133266-C2998055-308B-4F9B-8017-0E7D57E9409EQ37137408-DD1BDC0F-666A-4E9B-88BF-42DCCF9501F4Q37271937-FB608E12-8E6F-410D-BF69-5D21EE543CF1Q40440610-77514B62-63E7-48A5-85A5-B2EF853C5A2AQ47639841-453E4303-87F6-4BEE-9995-83DA328637AFQ48048562-AF3A39B4-F232-499B-A155-6EF675D83A1FQ51108541-142E8A41-71AD-4738-9023-9A6019F28A03Q52984624-C9A601A0-E538-42F1-854C-0261C898D688Q53360342-21F70680-A115-40C6-9328-DAE6F21E2228Q53706321-2C803A78-F7E6-427D-9D9F-28B3E702D737
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Evolution of the management of laryngeal cancer.
@ast
Evolution of the management of laryngeal cancer.
@en
Evolution of the management of laryngeal cancer.
@nl
type
label
Evolution of the management of laryngeal cancer.
@ast
Evolution of the management of laryngeal cancer.
@en
Evolution of the management of laryngeal cancer.
@nl
prefLabel
Evolution of the management of laryngeal cancer.
@ast
Evolution of the management of laryngeal cancer.
@en
Evolution of the management of laryngeal cancer.
@nl
P2093
P1433
P1476
Evolution of the management of laryngeal cancer.
@en
P2093
Adam S Jacobson
Alessandra Rinaldo
Alfio Ferlito
C René Leemans
Carl E Silver
Carlos Suárez
Eric M Genden
Patrick J Bradley
P304
P356
10.1016/J.ORALONCOLOGY.2006.08.007
P407
P577
2006-11-16T00:00:00Z